Nanox Imaging Ltd. (NASDAQ:NNOX) has entered into a clinical collaboration with Meir Medical Center to assess the diagnostic effectiveness of its Nanox.ARC system for orthopedic injuries in emergency care settings.
The study will compare imaging results from the Nanox.ARC with the hospital’s current diagnostic approach, which typically involves standard X-rays or X-rays followed by CT scans. The objective is to determine whether Nanox’s system can deliver more detailed anatomical insights and enable faster clinical decisions in cases involving trauma and high-impact injuries.
The Nanox.ARC is a multisource digital tomosynthesis platform designed to generate 3D images at a lower cost and with reduced radiation exposure compared to conventional CT scans. It is intended for tomographic imaging across areas such as the musculoskeletal system, lungs, abdomen, and sinuses in adult patients.
“This collaboration with Meir Medical Center advances the ongoing real-world clinical validation of the Nanox.ARC,” said Erez Meltzer, CEO and Acting Chairman of Nanox. “Partnerships with leading institutions like Meir, one of Israel’s largest hospital networks, are essential to building the clinical evidence base that will support broader adoption of our technology.”
Professor Nissim Ohana, Head of the Orthopedic Division at Meir Medical Center, said the study will test the system in live emergency scenarios, with the potential to enhance fracture detection.
The research will also examine whether introducing Nanox.ARC at early triage stages can improve efficiency and reduce radiation exposure within the diagnostic pathway. The study will be conducted under a formal protocol approved by Meir’s Helsinki Committee.
Meir Medical Center, part of Clalit Health Services, serves around one million residents in Israel’s Sharon region. The 801-bed hospital handles more than 60,000 admissions and approximately 190,000 emergency visits each year.